<DOC>
	<DOCNO>NCT00538265</DOCNO>
	<brief_summary>An open-label randomized multicenter clinical study compare three regime immunosuppression : ( A ) tacrolimus steroid , ( B ) antithymocyte induction therapy full dose tacrolimus , ( C ) antithymocyte induction therapy mycophenolate mofetil reduce dose tacrolimus .</brief_summary>
	<brief_title>Benefit Immunoprophylaxis Fibrosis Reduce Viral Load After Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>patient receive first liver transplantation , present qualitative quantitative PCR positive hepatitis C virus time transplantation , whatever transaminase activity , Women childbearing potential negative pregnancy test , Male female patient agree use effective method contraception , patient sign write informed consent form participate study , patient compliant likely follow visit specify study protocol • Preoperative serious renal impairment ( serum creatinine level &gt; 200 µmol/l ) , repeat transplantation , multiple organ transplantation , transplantation perform organ transplant obtain live donor reduce share organ graft , serious concomitant disorder , positive serology HBs antigen HIV positive time enrollment , previous history nonhepatic cancer ( except localize skin cancer ) , presence hepatocellular carcinoma , primary lesion exceed 5 cm complicate portal thrombosis metastatic disease , investigational product therapy administer less one month entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>liver transplantation , hepatitis C virus , immunoprophylaxis</keyword>
</DOC>